Phosphodiesterase inhibition promotes the transition from compensated hypertrophy to cardiac dilatation in rats

Pflugers Archiv European Journal of Physiology

Volumn 451, Issue 4, 2006, Pages 526-533

  Anamourlis, Christopher ^a   Badenhorst, Danelle ^a   Gibbs, Mark ^a   Correia, Raul ^a   Veliotes, Demetri ^a   Osadchii, Oleg ^a   Norton, Gavin R ^a   Woodiwiss, Angela J ^a  

^a UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

Author keywords

Adrenoreceptors; Cardiac dilatation; Collagen; Phosphodiesterase inhibitors

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; COLLAGEN; CYCLIC AMP; PENTOXIFYLLINE; PHOSPHODIESTERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE COURSE; ENZYME INHIBITION; GEOMETRY; HEART DILATATION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE WALL; HEART VENTRICLE HYPERTROPHY; INOTROPISM; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLE;

ANIMALS; BLOOD PRESSURE; CARDIOMEGALY; COLLAGEN; CYCLIC AMP; HEART; MYOCARDIAL CONTRACTION; ORGAN SIZE; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; VENTRICULAR REMODELING;

EID: 29044448413     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-005-1490-7     Document Type: Article

References (29)

1. Badenhorst D, Maseko M, Tsotetsi OJ, Naidoo A, Brooksbank R, Norton GR, Woodiwiss AJ (2003) Cross-linking influences the impact of quantitative changes in myocardial collagen on cardiac stiffness and remodelling in hypertension in rats. Cardiovasc Res 57:632-641
2. Badenhorst D, Veliotes D, Maseko M, Tsotetsi OJ, Brooksbank R, Naidoo A, Woodiwiss AJ, Norton GR (2003) β-adrenergic activation initiates chamber dilatation in concentric hypertrophy. Hypertension 41:499-504
3. Bing OHL, Brooks WW, Robinson KG, Slawsky MT, Hayes JA, Litwin SE, Sen S, Conrad CH (1995) The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure. J Mol Cell Cardiol 27:383-396
4. Bogoyevitch MA, Andersson MB, Gillespie-Brown J, Clerk A, Glennon PE, Fuller SJ, Sugden PH (1996) Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy. Biochem J 314:115-121
5. Castellano M, Beschi M, Rizzoni D, Paul M, Bohm M, Mantero G, Bettoni G, Porteri E, Albertini A, Agabiti-Rosei E (1993) Gene expression of cardiac beta1-adrenergic receptors during the development of hypertension in sponataneously hypertensive rats. J Hypertens 11:787-791
6. Chung ES, Perlini S, Aurigemma GP, Fenton RA, Dobson JG, Meyer TE (1998) Effects of chronic adenosine uptake blockade on adrenergic responsiveness and left ventricular chamber function in pressure overload hypertrophy in the rat. J Hypertens 16:1813-1822
7. Cohn JN, Levine TB, Olivari MT, Carberg V, Lara D, Francis CS, Simon AB, Rector T (1984) Plasma norepinephrine as a guide to prognosis in patients with congestive heart failure. N Engl J Med 311:819-823
8. Cohn JN, Ferrari R, Sharpe N (2000) Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol 35:569-582
9. Jain P, Brown EJ, Langenback EG, Raeder E, Lillis O, Halpern J, Mannisi JA (1991) Effects of milrinone on left ventricular remodeling after acute myocardial infarction. Circulation 84:796-804
10. Kelm M, Schafer S, Mingers S, Heythausen M, Vogt M, Motz W, Strauer BE (1996) Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients. J Hypertens 14:1365-1367
11. Leicht M, Greipel N, Zimmer H-G (2000) Comitogenic effect of catecholamines on rat cardiac fibroblasts in culture. Cardiovasc Res 48:274-284
12. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322:1561-1566
13. Li YY, Feng Y, McTiernan C, Pei W, Moravec CS, Wang P, Rosenblum W, Kormos RL, Feldman AM (2001) Down-regulation of matrix metalloproteinases and reduction in collagen damage in the failing heart after support with a left ventricular assist support device. Circulation 104:1147-1152
14. Moolman JA, Genade S, Tromp E, Lochner A (1996) Acomparison between ischemic preconditioning and anti-adrenergic interventions: cAMP, energy metabolism and functional recovery. Basic Res Cardiol 91:219-223
15. Norton GR, Tsotetsi OJ, Woodiwiss AJ (1993) Hydrochlorothiazide improves ventricular compliance and thus performance without reducing hypertrophy in renal artery stenosis in rats. Hypertension 21:638-645
16. Norton GR, Tsotetsi J, Trifunovic B, Hartford C, Candy GP, Woodiwiss AJ (1997) Myocardial stiffness is attributed to alterations in cross-linked collagen rather than total collagen or phenotypes in spontaneously hypertensive rats. Circulation 96:1991-1998
17. Norton GR, Woodiwiss AJ, Gaasch WH, Mela T, Chung ES, Aurigemma GP, Meyer TE (2002) Heart failure in pressure overload hypertrophy: the relative roles of ventricular remodeling and myocardial dysfunction. J Am Coll Cardiol 39:664-667
18. Packer M, Carver JR, Rodeheffer RJ, Ivan hoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, Mallis GI, Sollano JA, Shannon J, Tandon PK, Demets DL (1991) Effect of milrinone on mortality in severe chronic heart failure. N Engl J Med 325:1468-1475
19. Sabbah HN (1999) The cellular and physiologic effects of beta blockers in heart failure. Clin Cardiol 22:16-20
20. Sahn DJ, De Maria A, Kisslo J, Weyman A (1978) Recommendations regarding quantitation of M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072-1083
21. Schlaich MP, Kaye DM, Lambert E, Sommerville M, Socratous F, Esler MD (2003) Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation 108:560-565
22. Stegemann H, Stalder K (1967) Determination of hydroxyproline. Clin Chem Acta 18:267-273
23. Tsotetsi OJ, Woodiwiss AJ, Netjhardt M, Qubu D, Brooksbank R, Norton GR (2001) Attenuation of cardiac failure, dilatation, damage, and detrimental interstitial remodeling without regression of hypertrophy in hypertensive rats. Hypertension 38:846-851
24. Villarreal FJ, Kim NN, Ungab GD, Printz MP, Dillmann WH (1993). Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 88:2849-2861
25. Vittone L, Chiappe LE, Argel MI, Cingolani HE, Chiappe GE (1980) The mechanical and biochemical effects of pentoxifylline on the perfused rat heart. Experientia 36:1088-1090
26. Weber KT, Janicki JS, Shroff SG, Pick R, Chen RM, Bashey RI (1988) Collagen remodeling of the pressure-overloaded, hypertrophied non-human primate myocardium. Circ Res 62:757-776
27. Weishaar RE, Kobylarz-Singer DC, Steffen RP, Kaplan HR (1987) Subclasses of cyclic AMP-specific phosphodiesterase in left ventricular muscle and their involvement in regulating myocardial contractility. Circ Res 61:539-547
28. Woodiwiss AJ, Norton GR (1995) Exercise-induced cardiac hypertrophy is associated with an increased myocardial compliance. J Appl Physiol 78:1303-1311
29. Woodiwiss AJ, Tsotetsi OJ, Sprott S, Lancaster EJ, Mela T, Chung ES, Meyer TE, Norton GR (2001) Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction. Circulation 103:155-160